Sivaporn Sivasinprasasn

Chiang Rai, 57100, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Inhibition of Mitochondrial Fission by Mdivi-1 Alleviates Doxorubicin-Induced Nephrotoxicity in a Rat Model of D-Galactose-Induced Accelerated Renal Aging.

Inhibition of Mitochondrial Fission by Mdivi-1 Alleviates Doxorubicin-Induced Nephrotoxicity in a Rat Model of D-Galactose-Induced Accelerated Renal Aging.

Journal: Biomolecules

Published: July 04, 2026

N-Acetylcysteine enhances low-dose estrogen efficacy against ischemia-reperfusion injury in estrogen-deprived obese insulin-resistant rats.

N-Acetylcysteine enhances low-dose estrogen efficacy against ischemia-reperfusion injury in estrogen-deprived obese insulin-resistant rats.

Journal: Menopause (New York, N.Y.)

Published: December 03, 2024

Sexual dimorphism in cardiometabolic and cardiac mitochondrial function in obese rats following sex hormone deprivation.

Sexual dimorphism in cardiometabolic and cardiac mitochondrial function in obese rats following sex hormone deprivation.

Journal: Nutrition & diabetes

Published: December 14, 2020

N-acetylcysteine with low-dose estrogen reduces cardiac ischemia-reperfusion injury.

N-acetylcysteine with low-dose estrogen reduces cardiac ischemia-reperfusion injury.

Journal: The Journal of endocrinology

Published: May 02, 2019

Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.

Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.

Journal: The Journal of endocrinology

Published: November 06, 2017

Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats.

Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats.

Journal: Menopause (New York, N.Y.)

Published: March 15, 2017

DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats.

DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats.

Journal: Scientific reports

Published: September 26, 2016

Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats.

Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats.

Journal: The Journal of endocrinology

Published: August 16, 2016

Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats.

Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats.

Journal: Menopause (New York, N.Y.)

Published: June 22, 2016

Testosterone deprivation accelerates cardiac dysfunction in obese male rats.

Testosterone deprivation accelerates cardiac dysfunction in obese male rats.

Journal: The Journal of endocrinology

Published: February 23, 2016

Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury.

Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury.

Journal: Journal of cardiovascular translational research

Published: November 17, 2015

Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats.

Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats.

Journal: Age (Dordrecht, Netherlands)

Published: January 02, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026